Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viaskin Peanut in peanut allergy
NCT01675882Phase 2Completed
- Sponsor
- DBV Technologies
- Start
- Aug 2012
- Primary completion
- Jul 2014
- Modality
- Transdermal Patches
- Countries
- 5
01
Overview
A Phase 2 trial of peanut protein in peanut allergy, sponsored by DBV Technologies. Started Aug 2012; status: completed.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT01675882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675882.